Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

February 28, 2019

Conditions
Rabies
Interventions
DRUG

Chloroquine

FDA approve dosing schedule

DRUG

Atovaquone and Proguanil

FDA approve dosing schedule

DRUG

Doxycycline

FDA approve dosing schedule

BIOLOGICAL

Rabies Vaccine

FDA approve dosing schedule

Trial Locations (1)

13210

State University of New York, Upstate Medical University (SUNY-UMU), Syracuse

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

Kansas State University

OTHER

lead

State University of New York - Upstate Medical University

OTHER

NCT02564471 - Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. | Biotech Hunter | Biotech Hunter